Universidad de Cartagena
Cartagena, Departamento de Bolívar, 130012, Colombia
NCT Number: NCT05339048
Cardiovascular and respiratory diseases are the first and third cause of death, respectively. Cardiovascular risk is known to increase in groups with impaired lung function; however, the mechanisms behind this association are not fully understood. The aim of CaReS is to elucidate the shared pathophysiology of impaired lung function and cardiovascular risk, and to investigate the risk factors associated with them.
The CaReS Cohort Study includes adults (18-80 years old) from Cartagena de Indias, a tropical city on Colombian Caribbean Coast, where recent population admixture settled a three-hybrid genetic structure (European, African and Ameridian ancestry). At baseline, the cohort will generate extensive data on -omics (e.g., genomics, transcriptomics, metabolomics, and epigenomics), socio-economic wellbeing, lifestyle, medical history, cardiometabolic, inflammatory and liver function markers, as well as objective measures of ventilatory and cardiovascular performance.
The cohort will collect data every three years, for a total period of ten years. Prospective risk of cardiovascular disease and chronic obstructive pulmonary disease (COPD) will be investigated, and their risk factors. Throughout the study period, changes in prevalence, and interactions of various risk factors with these changes will also be ascertained.
A predictive risk score for cardiovascular and chronic respiratory disability will be built, using cross-sectional and longitudinal data.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Cartagena, Departamento de Bolívar, 130012, Colombia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exposure: Genetic predisposition to complex diseases.
Exposure: dietary intake of unhealthy foods known to be associated with higher prevalence of respiratory and cardiovascular diseases.
Exposure: frequency of moderated or intense physical activity, and daily exposure to sedentary behavior.
Exposure: socio-economic vulnerability indexes associated with higher prevalence of respiratory and cardiovascular diseases (including household conditions, accessibility to health care services, among others).
Time frame: baseline - 10 years (end of follow up)
Carotid atheroma identified by eco-doppler imaging test
Time frame: 2nd year (first follow up) - 10 years (end of follow up)
Record of acute coronary heart disease, miocardipathy, and ischemic or hemorragic cerebrovascular event.
Time frame: baseline - 10 years (end of follow up)
Obstruction patterns in post-bronchodilator spirometry.
Time frame: baseline - 10 years (end of follow up)
Pathologic findings for blood pressure, triglycerides, HDLc, serum glucose, and/or enlarged waist circumference (three or more of this criteria found simultaneously)
Time frame: baseline - 10 years (end of follow up)
Diagnosis of by lung function test (post-bronchodilator spirometry) and/or clinical criteria
Time frame: baseline - 10 years (end of follow up)
Primary high blood pressure according to clinical criteria
Time frame: baseline - 10 years (end of follow up)
Abnormal results in fasting serum glucose test and/or HbA1c test.
Time frame: baseline - 10 years (end of follow up)
High serum cholesterol, triglycerides or LDLc; and/or low HDLc
Universidad de Cartagena
Other
Observational Study for the Analysis of Associations Between Cardiovascular and Respiratory Diseases in a Cohort of Latin American Adults
Acronym: CaReS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06652776
Bronchial Diseases, Bronchitis
Milan, Italy
View Trial DetailsNCT07613294
Arterial Occlusive Diseases, Arteriosclerosis
La Jolla, California, United States
View Trial DetailsNCT06692127
Arterial Occlusive Diseases, Arteriosclerosis
Copenhagen, Denmark
View Trial DetailsNCT02991703
Arterial Occlusive Diseases, Arteriosclerosis
Nantes, France
View Trial Details